Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Yen

Showing results (281-290 of 347) with videos related to

Pageof 35
Sort By:
Chemical Communications (Cambridge, England)|May 20, 2014
Efficient delayed fluorescence via triplet-triplet annihilation for deep-blue electroluminescenceP-Y Chou, H-H Chou, Y-H Chen, et al.
Oncogene|February 17, 2015
Targeting the glucose-regulated protein-78 abrogates Pten-null driven AKT activation and endometrioid tumorigenesisY G Lin, J Shen, E Yoo, et al.
The Journal of Investigative Dermatology|June 30, 2015
Cyclic Alopecia and Abnormal Epidermal Cornification in Zdhhc13-Deficient Mice Reveal the Importance of Palmitoylation in Hair and Skin DifferentiationKai-Ming Liu, Yi-Ju Chen, Li-Fen Shen, et al.
Infection|May 17, 2006
Fever of unknown origin in TaiwanC Chin, Y-S Chen, S S-J Lee, et al.
The American Journal of Medicine|August 11, 2001
Eosinophilic meningitis caused by Angiostrongylus cantonensis: report of 17 casesH C Tsai, Y C Liu, C M Kunin, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|October 21, 2016
Immunohistochemical studies and fluorodeoxyglucose uptake on positron emission tomography in pharyngeal cancer for predicting radiotherapy-based treatment outcomesY-C Lin, R-Y Chen, S-W Chen, et al.
Leukemia|December 18, 2010
The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survivalA Scuto, P Krejci, L Popplewell, et al.
Journal of Medicinal Chemistry|September 28, 2017
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and VorinostatLianbin Yao, Nurulhuda Mustafa, Eng Chong Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignanciesM L Tetef, T W Synold, W Chow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survivalG Somlo, J H Doroshow, S J Forman, et al.
Pageof 35

Showing results (281-290 of 347) with videos related to

Sort By:
Pageof 35
Chemical Communications (Cambridge, England)|May 20, 2014
Efficient delayed fluorescence via triplet-triplet annihilation for deep-blue electroluminescenceP-Y Chou, H-H Chou, Y-H Chen, et al.
Oncogene|February 17, 2015
Targeting the glucose-regulated protein-78 abrogates Pten-null driven AKT activation and endometrioid tumorigenesisY G Lin, J Shen, E Yoo, et al.
The Journal of Investigative Dermatology|June 30, 2015
Cyclic Alopecia and Abnormal Epidermal Cornification in Zdhhc13-Deficient Mice Reveal the Importance of Palmitoylation in Hair and Skin DifferentiationKai-Ming Liu, Yi-Ju Chen, Li-Fen Shen, et al.
Infection|May 17, 2006
Fever of unknown origin in TaiwanC Chin, Y-S Chen, S S-J Lee, et al.
The American Journal of Medicine|August 11, 2001
Eosinophilic meningitis caused by Angiostrongylus cantonensis: report of 17 casesH C Tsai, Y C Liu, C M Kunin, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|October 21, 2016
Immunohistochemical studies and fluorodeoxyglucose uptake on positron emission tomography in pharyngeal cancer for predicting radiotherapy-based treatment outcomesY-C Lin, R-Y Chen, S-W Chen, et al.
Leukemia|December 18, 2010
The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survivalA Scuto, P Krejci, L Popplewell, et al.
Journal of Medicinal Chemistry|September 28, 2017
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and VorinostatLianbin Yao, Nurulhuda Mustafa, Eng Chong Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignanciesM L Tetef, T W Synold, W Chow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survivalG Somlo, J H Doroshow, S J Forman, et al.
Pageof 35